Avoid common mistakes on your manuscript.
Additional contact precautions (ACP) have been endorsed by International Recommendations in patients with colonisation or infection by multidrug-resistant organisms (MDRO) [1, 2]. Contact isolation (CI), considered initially as the holy grail of the interruption of transmission of MDROs, currently remains debated [3, 4]. Suboptimal contact of healthcare personnel with the patients has been associated with service care errors including falls, pressure ulcers, fluid/electrolyte disorders and suboptimal documentation of vital signs or physician notes. Patients’ dissatisfaction and stress as well as increased healthcare costs are the major downsides of CI [3]. In view of the divergent opinions in the literature, infection control practices in ICU vary considerably. In this narrative review, we will focus on the most relevant studies, with messages in line with the principle “less is more” (Table 1). In the present manuscript, we considered “less CI” as surrogate to “not universal" or “targeted” CI (and evidently not “no CI”). However, we also discuss studies in which CI seems less important or less effective compared to other pivotal infection control measures, therefore, less desirable. Search methods are shown in Supplement Table.
The efficacy of CI over properly enforced standard precautions with particular focus on adherence to hand hygiene has been questioned. Huskins et al. performed universal screening of patients and then pre-emptive isolation followed by barrier precautions for identified carriers; no significant change in acquisition of MRSA or VRE was demonstrated [4]. Also, Cepeda et al. showed that transfer of MRSA-colonised patients into single rooms or cohorting did not confer to reduced cross-infection [5]
As far as MDR Gram-negative bacteria (MDR-GNB) are concerned, despite international recommendations, no single infection control approach (and particularly not CI) alone was associated with positive outcomes, especially in endemic settings. A recent systematic review and network meta-analysis evaluating (1) standard care (including contact precautions), (2) antimicrobial stewardship, (3) environmental cleaning, (4) source control or (5) decolonization methods for the prevention of multidrug-resistant Gram-negative bacteria (MDR-GNB) in adult Intensive Care Units (ICUs) showed that only four-component strategies adopting components (1)–(5) were effective to prevent MDR-GNB acquisition [6]. Environmental cleaning seems important component for Acinetobacter baumannii, whereas decolonization strategy was pivotal in K. pneumoniae albeit data derived from low endemicity settings [6]. Sypsa et al. using a Ross-Macdonald model, showed that screening, contact precautions and particularly hand hygiene among a multifaceted infection control bundle (including CI), were the major contributors in the containment of Carbapenemase-producing Klebsiella pneumonia in an endemic surgical setting [7]. In this study, cohorting was more common than strict isolation due to intrinsic institutional barriers. Nevertheless, less strict isolation may still prove to be highly effective, provided that contact precautions remain fully functional.
In a prospective multicenter ICU trial by Derde and colleagues, in the context of a rigorous compliance with hand hygiene and universal chlorhexidine body washing, screening and CI of carriers do not reduce acquisition rates of MDRO, irrespective of rapid or conventional screening. However, a reduction in MRSA acquisition was noted [8]. Data from the previous and other studies argue for targeted and non-universal screening and CI measures in endemic environments or outbreaks by ESBL-producing non-Escherichia coli Enterobacterales, whereas ESBL-E. coli seems to be associated with less CI demands, particularly in settings where effective standard precautions are in place [9].
Ledoux et al., in a before–after single-center non-inferiority study, showed that a targeted isolation strategy at ICU admission was not inferior to a systematic isolation strategy regarding ICU-acquired infection related to MDRO (including key resistant both Gram-positive and -negative pathogens). With the targeted approach, CI was avoided in almost one-third of patients [10]. In another sequential single-center observational study in a surgical ICU, the authors showed that a targeted isolation screening policy on ICU admission was safe compared with universal screening and isolation, resulting in similar rates of ICU-acquired MDRO colonization or infection during both study periods [11].
On the other hand, many studies have shown an increased rate of undesirable adverse events associated with CI [3]. In a study comparing the frequency of adverse events according to the isolation status in an ICU cohort population, the authors found five medication errors or adverse events that were significantly more frequently observed in patients under strict isolation: hypoglycaemia, hyperglycaemia, errors in administration of anticoagulants and ventilator-associated pneumonia (VAP) due to MDRO [12]. Searcy et al. showed that CI for MRSA colonisation was associated with over-sedation, prolonged ICU stay and mechanical ventilation [Searcy] [13].
Isolation capability varies across countries and settings. Dhar et al. showed that as the need for isolation is increasing, compliance with other measures is decreasing. There was a threshold of 40% for isolation within the unit, above which compliance with CI precautions (particularly hand hygiene) dropped significantly [14]. In a mathematic model, Gurieva et al. have shown that isolation capability is a major determinant of cost-saving curves. Targeted patient screening (based on previous carrier status) combined with screening of ICU-patients was the most cost-effective strategy when associated with an isolation capability of 25%. Better isolation capability is expected to render more extended screening strategies cost saving [15]. Therefore, CI local recommendations should be balanced on these issues.
We are convinced that CI will remain an important aspect of infection control, yet not the holy grail. Scientific evidence questioning its pivotal role particularly in the multifactorial arena of MDR-GNB persistence, permit us to state: “Less CI”, is probably “more” in the ICU setting. Targeted and locally adapted contact isolation practices can avoid undesired adverse events in the patient’s management, spare healthcare financial and human resources to be allocated in other preventive components, and obviate patient-family stress. Its contribution in contemporary medicine cannot be viewed without rapid screening tools to be applied to targeted group of patients and certainly without strictly supervised hand hygiene. However, purpose-constructed studies are required to verify actual ranking of infection control components in each epidemiologic milieu.
References
Yokoe DS, Anderson DJ, Berenholtz SM, Calfee DP, Dubberke ER, Ellingson KD, Gerding DN, Haas JP, Kaye KS, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle LE, Salgado CD, Bryant K, Classen D, Crist K, Deloney VM, Fishman NO, Foster N, Goldmann DA, Humphreys E, Jernigan JA, Padberg J, Perl TM, Podgorny K, Septimus EJ, VanAmringe M, Weaver T, Weinstein RA, Wise R, Maragakis LL, Society for Healthcare Epidemiology of America (SHEA) (2014) A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol 35(967):977. https://doi.org/10.1086/677216
Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, Kahlmeter G, Pan A, Petrosillo N, Rodríguez-Baño J, Singh N, Venditti M, Yokoe DS, Cookson B, European Society of Clinical Microbiology (2014) ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20(1):55. https://doi.org/10.1111/1469-0691.12427
Landelle C, Pagani L, Harbarth S (2013) Is patient isolation the single most important measure to prevent the spread of multidrug-resistant pathogens? Virulence 4:163–171. https://doi.org/10.4161/viru.22641
Huskins WC, Huckabee CM, O'Grady NP, Murray P, Kopetskie H, Zimmer L, Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D, Goldmann DA, STAR*ICU Trial Investigators (2011) Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 364:1407–1418. https://doi.org/10.1056/NEJMoa1000373
Cepeda JA, Whitehouse T, Cooper B, Hails J, Jones K, Kwaku F, Taylor L, Hayman S, Cookson B, Shaw S, Kibbler C, Singer M, Bellingan G, Wilson AP (2005) Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365:295–304. https://doi.org/10.1016/S0140-6736(05)17783-6
Teerawattanapong N, Kengkla K, Dilokthornsakul P, Saokaew S, Apisarnthanarak A, Chaiyakunapruk N (2017) Prevention and control of multidrug-resistant gram-negative bacteria in adult intensive care units: a systematic review and network meta-analysis. Clin Infect Dis 64:S51–S60. https://doi.org/10.1093/cid/cix112
Sypsa V, Psichogiou M, Bouzala GA, Hadjihannas L, Hatzakis A, Daikos GL (2012) Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit. PLoS ONE 7:e41068. https://doi.org/10.1371/journal.pone.0041068
Derde LPG, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJL, Gniadkowski M, Hryniewicz W, Empel J, Dautzenberg MJD, Annane D, Aragão I, Chalfine A, Dumpis U, Esteves F, Giamarellou H, Muzlovic I, Nardi G, Petrikkos GL, Tomic V, Martí AT, Stammet P, Brun-Buisson C, Bonten MJM, MOSAR WP3 Study Team (2014) Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 14(31):39. https://doi.org/10.1016/S1473-3099(13)70295-0
Zahar JR, Blot S, Nordmann P, Martischang R, Timsit JF, Harbarth S, Barbier F (2019) Screening for intestinal carriage of extended-spectrum beta-lactamase-producing enterobacteriaceae in critically Ill patients: expected benefits and evidence-based controversies. Clin Infect Dis 68:2125–2130. https://doi.org/10.1093/cid/ciy864
Ledoux G, Six S, Lawson R, Labreuche J, Blazejewski C, Wallet F, Duhamel A, Nseir S (2016) Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive-care-unit-acquired infection related to multidrug-resistant bacteria: a prospective uncontrolled before-after study. Clin Microbiol Infect 22:888.e11–888.e18. https://doi.org/10.1016/j.cmi.2016.07.012
Djibré M, Fedun S, Le Guen P, Vimont S, Hafiani M, Fulgencio JP, Parrot A, Denis M, Fartoukh M (2017) Universal versus targeted additional contact precautions for multidrug-resistant organism carriage for patients admitted to an intensive care unit. Am J Infect Control 45:728–734. https://doi.org/10.1016/j.ajic.2017.02.001
Zahar JR, Garrouste-Orgeas M, Vesin A, Schwebel C, Bonadona A, Philippart F, Ara-Somohano C, Misset B, Timsit JF (2013) Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events. Intensive Care Med 39:2153–2160. https://doi.org/10.1007/s00134-013-3071-0
Searcy RJ, Jankowski CA, Johnson DW, Ferreira JA (2018) Evaluation of sedation-related medication errors in patients on contact isolation in the intensive care unit. J Hosp Infect 98:175–180. https://doi.org/10.1016/j.jhin.2017.06.025
Dhar S, Marchaim D, Tansek R, Chopra T, Yousuf A, Bhargava A, Martin ET, Talbot TR, Johnson LE, Hingwe A, Zuckerman JM, Bono BR, Shuman EK, Poblete J, Tran M, Kulhanek G, Thyagarajan R, Nagappan V, Herzke C, Perl TM, Kaye KS (2014) Contact precautions: more is not necessarily better. Infect Control Hosp Epidemiol 35:213–221. https://doi.org/10.1086/675294
Gurieva T, Bootsma MC, Bonten MJ (2012) Successful Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections revisited. Clin Infect Dis 54:1618–1620. https://doi.org/10.1093/cid/cis272
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Poulakou reports personal fees from MSD, personal fees from Pfizer, personal fees from Biorad, personal fees from Menarini, personal fees from Angelini, outside the submitted work. Dr. Nseir reports personal fees from MSD, personal fees from Pfizer, personal fees from Gilead, personal fees from bioMérieux, personal fees from Bio-Rad, outside the submitted work. Dr. Daikos reports grants and personal fees from Pfizer, personal fees from Menarini, personal fees from MSD, outside the submitted work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Poulakou, G., Nseir, S. & Daikos, G.L. Less contact isolation is more in the ICU: pro. Intensive Care Med 46, 1727–1731 (2020). https://doi.org/10.1007/s00134-020-06173-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-020-06173-5